DrugDashboards

Methylprednisolone Sodium Succinate

Methylprednisolone Sodium Succinate · METHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/1 · Injection, Powder, For Solution · Intramuscular; Intravenous · Civica, Inc.

NDC 72572-0097-25 · 25 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

10 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$46.75
Reported to Texas DSHS · 2026 annual filing · Civica, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 5 MG
$0.224
HCPCS J2919 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for methylprednisolone sodium succinate (injectable) in the next 90 days

sterile injectable · sole-source market · price up 4% YoY

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA203125
TE code
AP
Approval date
Sep 26, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Methylprednisolone Sodium Succinate (Injection, Powder, For Solution)

LabelerStrengthFirst seenLast seen
Cardinal Health 107, LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 1 g/1Jul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 3, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 1 g/mLJul 15, 2026Sep 3, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026
Civica, Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/1Jul 15, 2026Sep 2, 2026
Civica, Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/1Jul 15, 2026Sep 2, 2026
Henry Schein, Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 500 mg/1Jul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 500 mg/mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 1 g/8mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 2 g/30.6mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 500 mg/4mLJul 15, 2026Sep 2, 2026
ProPharma DistributionMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/1Jul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Aug 31, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Aug 31, 2026
Sportpharm LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 25, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Methylprednisolone Sodium Succinate — NDC 72572-0097-25," retrieved September 3, 2026, https://drugdashboards.com/drug/72572009725.

Free to cite with attribution — see how the data is put together.